RP 59,500 (quinupristin/dalfopristin): A new streptogramin with potent activity against penicillin-resistant Streptococcus pneumoniae

Advances in Therapy

Volumn 15, Issue 3, 1998, Pages 158-164

  Aldridge, Kenneth E ^a  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

Author keywords

Multiple resistance; Penicillin resistance; RP59500 (quinupristin dalfopristin); S. pneumoniae

Indexed keywords

CEFOTAXIME; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; IMIPENEM; OFLOXACIN; PENICILLIN G; STREPTOGRAMIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; DRUG POTENCY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0031818632     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Centers for Disease Control and Prevention. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR. 1996;45(suppl):1-14.
2. Applebaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumonine. Pediatr Infect Dis J. 1996;15:932-939.
3. Hansman D, Bullen MM. A resistant pneumococcus. Lancet. 1967;2:264-265.